• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种应用于突变特征的半参数核独立性检验。

A semiparametric kernel independence test with application to mutational signatures.

作者信息

Lee DongHyuk, Zhu Bin

机构信息

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

J Am Stat Assoc. 2021;116(536):1648-1661. doi: 10.1080/01621459.2020.1871357. Epub 2021 Feb 16.

DOI:10.1080/01621459.2020.1871357
PMID:35515712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9070557/
Abstract

Cancers arise owing to somatic mutations, and the characteristic combinations of somatic mutations form mutational signatures. Despite many mutational signatures being identified, mutational processes underlying a number of mutational signatures remain unknown, which hinders the identification of interventions that may reduce somatic mutation burdens and prevent the development of cancer. We demonstrate that the unknown cause of a mutational signature can be inferred by the associated signatures with known etiology. However, existing association tests are not statistically powerful due to excess zeros in mutational signatures data. To address this limitation, we propose a semiparametric kernel independence test (SKIT). The SKIT statistic is defined as the integrated squared distance between mixed probability distributions and is decomposed into four disjoint components to pinpoint the source of dependency. We derive the asymptotic null distribution and prove the asymptotic convergence of power. Due to slow convergence to the asymptotic null distribution, a bootstrap method is employed to compute -values. Simulation studies demonstrate that when zeros are prevalent, SKIT is more resilient to power loss than existing tests and robust to random errors. We applied SKIT to The Cancer Genome Atlas (TCGA) mutational signatures data for over 9,000 tumors across 32 cancer types, and identified a novel association between signature 17 curated in the Catalogue Of Somatic Mutations In Cancer (COSMIC) and apolipoprotein B mRNA editing enzyme (APOBEC) signatures in gastrointestinal cancers. It indicates that APOBEC activity is likely associated with the unknown cause of signature 17.

摘要

癌症是由体细胞突变引起的,体细胞突变的特征组合形成了突变特征。尽管已经鉴定出许多突变特征,但一些突变特征背后的突变过程仍然未知,这阻碍了能够降低体细胞突变负担并预防癌症发生的干预措施的识别。我们证明,可以通过具有已知病因的相关特征来推断突变特征的未知原因。然而,由于突变特征数据中存在过多的零值,现有的关联检验在统计上缺乏效力。为了解决这一局限性,我们提出了一种半参数核独立性检验(SKIT)。SKIT统计量被定义为混合概率分布之间的积分平方距离,并被分解为四个不相交的分量以确定依赖源。我们推导了渐近零分布并证明了检验功效的渐近收敛性。由于向渐近零分布的收敛速度较慢,因此采用了一种自助法来计算p值。模拟研究表明,当零值普遍存在时,SKIT比现有检验对功效损失更具弹性,并且对随机误差具有鲁棒性。我们将SKIT应用于癌症基因组图谱(TCGA)中32种癌症类型的9000多个肿瘤的突变特征数据,并在癌症体细胞突变目录(COSMIC)中策划的特征17与胃肠道癌症中的载脂蛋白B mRNA编辑酶(APOBEC)特征之间发现了一种新的关联。这表明APOBEC活性可能与特征17的未知原因有关。

相似文献

1
A semiparametric kernel independence test with application to mutational signatures.一种应用于突变特征的半参数核独立性检验。
J Am Stat Assoc. 2021;116(536):1648-1661. doi: 10.1080/01621459.2020.1871357. Epub 2021 Feb 16.
2
Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.APOBEC突变特征升高提示慢性损伤与侵袭性头颈部鳞状细胞癌的病因有关:一例报告
J Med Case Rep. 2021 Apr 30;15(1):252. doi: 10.1186/s13256-021-02685-w.
3
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.APOBEC 诱变、kataegis、EGFR 突变奥希替尼耐药肺腺癌中的染色体重排。
Ann Oncol. 2022 Dec;33(12):1284-1295. doi: 10.1016/j.annonc.2022.09.151. Epub 2022 Sep 9.
4
The Use of Mutational Signatures to Decipher the Inter-Relationship of Reactive Oxygen Species with Homologous Recombination and Non-Homologous End-Joining Deficiencies as Well as Their Effects on APOBEC Mutagenesis in Breast Cancer.利用突变特征解读乳腺癌中活性氧与同源重组及非同源末端连接缺陷的相互关系及其对载脂蛋白B编辑酶催化多肽样3(APOBEC)诱变的影响
Cancers (Basel). 2025 May 12;17(10):1627. doi: 10.3390/cancers17101627.
5
Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.对 7815 个癌症外显子组的分析揭示了突变过程与体细胞驱动突变之间的关联。
PLoS Genet. 2018 Nov 9;14(11):e1007779. doi: 10.1371/journal.pgen.1007779. eCollection 2018 Nov.
6
: a web application to identify the most similar mutational signature using shiny.一个使用 shiny 来识别最相似突变特征的网络应用程序。
F1000Res. 2020 Jun 10;9:586. doi: 10.12688/f1000research.24435.2. eCollection 2020.
7
Somatic mutational profiles and germline polygenic risk scores in human cancer.体细胞突变特征与人类癌症的种系多基因风险评分
Genome Med. 2022 Feb 11;14(1):14. doi: 10.1186/s13073-022-01016-y.
8
Procarcinogen Activation and Mutational Signatures Model the Initiation of Carcinogenesis in Human Urothelial Tissues In Vitro.原癌基因激活和突变特征模型在人类尿路上皮组织体外诱导肿瘤发生。
Eur Urol. 2020 Aug;78(2):143-147. doi: 10.1016/j.eururo.2020.03.049. Epub 2020 Apr 27.
9
The role of distinct APOBEC/ADAR mRNA levels in mutational signatures linked to aging and ultraviolet radiation.不同 APOBEC/ADAR mRNA 水平在与衰老和紫外线辐射相关的突变特征中的作用。
Sci Rep. 2024 Jul 4;14(1):15395. doi: 10.1038/s41598-024-64986-6.
10
Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.美国和尼日利亚非洲裔和欧洲裔人群乳腺癌的种系变异和体细胞突变特征。
Int J Cancer. 2019 Dec 15;145(12):3321-3333. doi: 10.1002/ijc.32498. Epub 2019 Jun 27.

引用本文的文献

1
Dissecting gene expression heterogeneity: generalized Pearson correlation squares and the -lines clustering algorithm.剖析基因表达异质性:广义皮尔逊相关平方与 - 线聚类算法
J Am Stat Assoc. 2024;119(548):2450-2463. doi: 10.1080/01621459.2024.2342639. Epub 2024 May 24.

本文引用的文献

1
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
2
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
3
Local Determinants of the Mutational Landscape of the Human Genome.人类基因组突变景观的局部决定因素。
Cell. 2019 Mar 21;177(1):101-114. doi: 10.1016/j.cell.2019.02.051.
4
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis. characterizes mutational signatures in human cancer cell lines reveals episodic aPOBEC mutagenesis
Cell. 2019 Mar 7;176(6):1282-1294.e20. doi: 10.1016/j.cell.2019.02.012.
5
Analysis and correction of compositional bias in sparse sequencing count data.稀疏测序计数数据中组成偏差的分析与校正。
BMC Genomics. 2018 Nov 6;19(1):799. doi: 10.1186/s12864-018-5160-5.
6
A general and flexible method for signal extraction from single-cell RNA-seq data.一种从单细胞RNA测序数据中提取信号的通用且灵活的方法。
Nat Commun. 2018 Jan 18;9(1):284. doi: 10.1038/s41467-017-02554-5.
7
Clock-like mutational processes in human somatic cells.人类体细胞中类似时钟的突变过程。
Nat Genet. 2015 Dec;47(12):1402-7. doi: 10.1038/ng.3441. Epub 2015 Nov 9.
8
Assessment and Selection of Competing Models for Zero-Inflated Microbiome Data.零膨胀微生物组数据竞争模型的评估与选择
PLoS One. 2015 Jul 6;10(7):e0129606. doi: 10.1371/journal.pone.0129606. eCollection 2015.
9
Mechanisms underlying mutational signatures in human cancers.人类癌症中突变特征的潜在机制。
Nat Rev Genet. 2014 Sep;15(9):585-98. doi: 10.1038/nrg3729. Epub 2014 Jul 1.
10
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.APOBEC 胞嘧啶脱氨酶致突变模式广泛存在于人类癌症中。
Nat Genet. 2013 Sep;45(9):970-6. doi: 10.1038/ng.2702. Epub 2013 Jul 14.